BEAT BioTherapeutics
7 articles about BEAT BioTherapeutics
-
BEAT BioTherapeutics Announces Scientific Presentation At American Society Of Gene And Cell Therapy Annual Meeting
5/3/2016
-
BEAT BioTherapeutics’ BB-R12 Provides Significant Improvement In Cardiac Function In Heart Failure Study
6/4/2015
-
BEAT BioTherapeutics To Present New Data Supporting The Effectiveness Of BB-R12 In Treating Heart Failure
5/12/2015
-
BEAT BioTherapeutics dATP Technology Improves Cardiac Function In End Stage Human Heart Failure Cardiac Muscle
1/9/2015
-
BEAT BioTherapeutics Announces Scientific Presentations Of Promising New Heart Failure Treatment At The American Heart Association Meeting
11/14/2014
-
BEAT BioTherapeutics’ Co-Founder, D. Michael Regnier, To Present At American College of Cardiology Annual Meeting
3/28/2014
-
BEAT BioTherapeutics Appoints Dr. Sam L. Teichman As Chief Medical Officer
3/24/2014